Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NEURODEGENERATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Neurodegeneration refers to the progressive structural and functional loss of neurons. It is the hallmark of diseases including Alzheimer's, Parkinson's, ALS, Huntington's, and frontotemporal dementia. Shared mechanisms across neurodegenerative diseases include proteostasis failure, mitochondrial dysfunction, oxidative stress, synaptic loss, and neuroinflammation. These convergent pathways are key targets for therapeutic intervention.
No AI portrait yet
Knowledge base pages for this entity
graph TD
subgraph Pathology["Pathology"]
NEURODEGENERATION["NEURODEGENERATION"] -->|"associated with"| NEURON["NEURON"]
NEURODEGENERATION["NEURODEGENERATION"] -->|"associated with"| OLIGODENDROCYTE["OLIGODENDROCYTE"]
NEURODEGENERATION["NEURODEGENERATION"] -->|"associated with"| Neurodegeneration["Neurodegeneration"]
NEURODEGENERATION["NEURODEGENERATION"] -->|"associated with"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
NEURODEGENERATION["NEURODEGENERATION"] -->|"associated with"| Alzheimer["Alzheimer"]
TAU["TAU"] -->|"associated with"| NEURODEGENERATION["NEURODEGENERATION"]
APOPTOSIS["APOPTOSIS"] -->|"causes"| NEURODEGENERATION["NEURODEGENERATION"]
MS["MS"] -->|"causes"| NEURODEGENERATION["NEURODEGENERATION"]
FERROPTOSIS_2["FERROPTOSIS"] -->|"associated with"| NEURODEGENERATION["NEURODEGENERATION"]
end
subgraph Signaling["Signaling"]
NEURODEGENERATION["NEURODEGENERATION"] -->|"regulates"| Als["Als"]
NEURODEGENERATION["NEURODEGENERATION"] -->|"activates"| ALZHEIMER_S_DISEASE_1["ALZHEIMER'S DISEASE"]
NEURODEGENERATION["NEURODEGENERATION"] -->|"activates"| P62["P62"]
NEURODEGENERATION["NEURODEGENERATION"] -->|"activates"| FERROPTOSIS["FERROPTOSIS"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| NEURODEGENERATION["NEURODEGENERATION"]
TAU_3["TAU"] -->|"activates"| NEURODEGENERATION["NEURODEGENERATION"]
end
style NEURODEGENERATION fill:#5d4400,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style OLIGODENDROCYTE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Neurodegeneration fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style ALZHEIMER_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Alzheimer fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style ALZHEIMER_S_DISEASE_1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style P62 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style FERROPTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style TAU fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APOPTOSIS fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MS fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NEUROINFLAMMATION fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style FERROPTOSIS_2 fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style TAU_3 fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer | therapeutic_target | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Amyotrophic Lateral Sclerosis | activates | disease | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| FERROPTOSIS | activates | gene | 1.00 |
| NEURODEGENERATIVE DISORDERS | therapeutic_target | gene | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| Als | activates | disease | 1.00 |
| Apoptosis | therapeutic_target | pathway | 1.00 |
| Ferroptosis | activates | pathway | 1.00 |
| OLIGODENDROCYTE | associated_with | gene | 1.00 |
| Immune Response | therapeutic_target | pathway | 1.00 |
| AMYOTROPHIC LATERAL SCLEROSIS | therapeutic_target | gene | 1.00 |
| ALZHEIMER'S DISEASE | activates | gene | 1.00 |
| Ubiquitin-Proteasome | therapeutic_target | pathway | 1.00 |
| NEURODEGENERATIVE DISORDERS | activates | gene | 1.00 |
| Nf-Κb | activates | pathway | 1.00 |
| Neurodegeneration | therapeutic_target | disease | 1.00 |
| Blood-Brain Barrier | activates | pathway | 1.00 |
| Immune Response | activates | pathway | 1.00 |
| Mitophagy | therapeutic_target | pathway | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Ferroptosis | activates | pathway | 1.00 |
| Mitochondrial Function | therapeutic_target | pathway | 1.00 |
| Neurogenesis | activates | pathway | 1.00 |
| Phagocytosis | activates | pathway | 1.00 |
| P62 | activates | gene | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| Synaptic Plasticity | activates | pathway | 1.00 |
| Als | regulates | disease | 1.00 |
| Immune Response | regulates | pathway | 1.00 |
| Complement | activates | pathway | 1.00 |
| Mtor | activates | pathway | 1.00 |
| AMYOTROPHIC LATERAL SCLEROSIS | activates | gene | 1.00 |
| Oxidative Stress | therapeutic_target | pathway | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| ALS | activates | gene | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Blood-Brain Barrier | therapeutic_target | pathway | 1.00 |
| Oxidative Stress | regulates | pathway | 1.00 |
| Autophagy | therapeutic_target | pathway | 1.00 |
| Autophagy | regulates | pathway | 1.00 |
| Mtor | associated_with | pathway | 1.00 |
| Proteasome | therapeutic_target | pathway | 1.00 |
| Mitophagy | activates | pathway | 1.00 |
| Proteasome | activates | pathway | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| Apoptosis | regulates | pathway | 1.00 |
| Autophagy | inhibits | pathway | 1.00 |
| Huntington | therapeutic_target | disease | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| BBB_breakdown | accelerates | process | 0.00 |
| entities-hepcidin | associated_with | wiki | 0.00 |
| entities-reactive-oxygen-species | associated_with | wiki | 0.00 |
| entities-atp7b-gene | associated_with | wiki | 0.00 |
| entities-histone-methylation | associated_with | wiki | 0.00 |
| entities-ros | associated_with | wiki | 0.00 |
| Als | therapeutic_target | disease | 1.00 |
| Alzheimer | therapeutic_target | disease | 1.00 |
| Huntington | activates | disease | 1.00 |
| Als | inhibits | disease | 1.00 |
| Alzheimer | causes | disease | 1.00 |
| Amyotrophic Lateral Sclerosis | therapeutic_target | disease | 1.00 |
| Parkinson | therapeutic_target | disease | 1.00 |
| SIRT1 | activates | gene | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| Aging | regulates | disease | 1.00 |
| ALZHEIMER | inhibits | gene | 1.00 |
| AMYLOID | therapeutic_target | gene | 1.00 |
| MICROGLIA | expressed_in | gene | 1.00 |
| PARKINSON'S DISEASE | biomarker_for | gene | 1.00 |
| Als | activates | disease | 1.00 |
| ATP | activates | gene | 1.00 |
| AMYLOID | interacts_with | gene | 1.00 |
| MYELIN | activates | gene | 1.00 |
| CANCER | regulates | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| OXIDATIVE STRESS | activates | gene | 1.00 |
| NEURODEGENERATION | protects_against | gene | 1.00 |
| TNF | therapeutic_target | gene | 1.00 |
| ALZHEIMER'S DISEASE | protects_against | gene | 1.00 |
| PARKINSON'S DISEASE | inhibits | gene | 1.00 |
| NEURODEGENERATIVE DISEASES | biomarker_for | gene | 1.00 |
| AGING | activates | gene | 1.00 |
| ASTROCYTE | regulates | gene | 1.00 |
| ALZHEIMER | therapeutic_target | gene | 1.00 |
| ALZHEIMER | causes | gene | 1.00 |
| MITOCHONDRIA | therapeutic_target | gene | 1.00 |
| AGING | regulates | gene | 1.00 |
| ALZHEIMER'S DISEASE | regulates | gene | 1.00 |
| NEUROINFLAMMATION | therapeutic_target | gene | 1.00 |
| NEURODEGENERATIVE DISEASES | regulates | gene | 1.00 |
| MICROGLIA | therapeutic_target | gene | 1.00 |
| TAU PATHOLOGY | associated_with | gene | 1.00 |
| NF-ΚB | activates | gene | 1.00 |
| SYNAPSE | activates | gene | 1.00 |
| Cardiovascular | associated_with | disease | 1.00 |
| GENES | therapeutic_target | gene | 1.00 |
| AMYOTROPHIC LATERAL SCLEROSIS | regulates | gene | 1.00 |
| HUNTINGTON'S DISEASE | activates | gene | 1.00 |
| NEURODEGENERATIVE DISORDERS | regulates | gene | 1.00 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-28 | 7 hypotheses Top: 0.662
neurodegeneration | 2026-04-27 | 0 hypotheses
neurodegeneration | 2026-04-27 | 4 hypotheses Top: 0.680
neurodegeneration | 2026-04-27 | 3 hypotheses Top: 0.626
neurodegeneration | 2026-04-27 | 4 hypotheses Top: 0.675
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| nSMase2 Inhibitor DPTIP Rescues Synaptic Density in APPswe/PS1deltaE9 | in_vivo | Alzheimer's disease | 0.803 | 0.74 | APPswe/PS1dE9 bigenic mice, 6- | proposed | $62,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861] | ["Han X", "Sun S", "Sun Y", "Song Q", "Z | Autophagy | 2020 | 1 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438] | Hegdekar N, Sarkar C, Bustos S, Ritzel R | Autophagy | 2023 | 0 |
| Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's [PMID:37029500] | Yan YQ, Zheng R, Liu Y, Ruan Y, Lin ZH, | Aging cell | 2023 | 0 |
| Inflammasome assembly in neurodegenerative diseases. [PMID:37633753] | Singh J, Habean ML, Panicker N | Trends in neurosciences | 2023 | 0 |
| Microglial NLRP3 inflammasome activates neurotoxic astrocytes in depression-like [PMID:36288697] | Li S, Fang Y, Zhang Y, Song M, Zhang X, | Cell reports | 2022 | 0 |
| Biomarker of Neuroinflammation in Parkinson's Disease. [PMID:35456966] | Liu TW, Chen CM, Chang KH | Int J Mol Sci | 2022 | 0 |
| NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pat [PMID:34877938] | Li S, Sun Y, Song M, Song Y, Fang Y, Zha | JCI insight | 2021 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| NLRP3 inflammasome activation drives tau pathology. [PMID:31748742] | ["Ising C", "Venegas C", "Zhang S", "Sch | Nature | 2019 | 0 |
| Multiple Sclerosis Pathology. [PMID:29358320] | Lassmann H | Cold Spring Harbor perspective | 2018 | 0 |
| Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodeg [PMID:30381407] | Gordon R, Albornoz EA, Christie DC, Lang | Science translational medicine | 2018 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.57 · 2026-04-28
archived · Rounds: 2 · Score: 0.73 · 2026-04-28
closed · Rounds: 4 · Score: 0.76 · 2026-04-28
closed · Rounds: 4 · Score: 0.64 · 2026-04-28
closed · Rounds: 4 · Score: 0.67 · 2026-04-28
closed · Rounds: 4 · Score: 0.67 · 2026-04-28
closed · Rounds: 4 · Score: 0.67 · 2026-04-28
closed · Rounds: 6 · Score: 0.89 · 2026-04-27
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
Hypotheses and analyses mentioning NEURODEGENERATION in their description or question text
Score: 0.822 · neurodegeneration · 2026-04-05
## Mechanistic Overview Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-Synuclein Aggregates Drives Non-Cell-
Score: 0.819 · neurodegeneration · 2026-04-28
This hypothesis proposes that CYP46A1 overexpression gene therapy prevents neurodegeneration by disrupting the pathologi
Score: 0.805 · neurodegeneration · 2026-04-05
## Mechanistic Overview Mitochondrial DAMPs-Driven AIM2 Inflammasome Activation in Neurodegeneration starts from the cla
Score: 0.804 · neurodegeneration · 2026-04-05
## Mechanistic Overview Calcium-Dysregulated mPTP Opening as an Alternative mtDNA Release Mechanism for AIM2 Inflammasom
Score: 0.803 · neurodegeneration · 2026-04-05
## Mechanistic Overview Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neurodegeneration starts from the claim
Score: 0.745 · unknown disease · 2026-04-26
Soluble PDGFRβ (sPDGFRβ) is released into the bloodstream upon pericyte damage, serving as a peripheral indicator of blo
Score: 0.716 · neurodegeneration · 2026-04-12
## Mechanistic Overview TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration starts from the claim that m
Score: 0.708 · neurodegeneration · 2026-04-12
## Mechanistic Overview TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegeneration starts from the claim that mo
Score: 0.705 · unknown disease · 2026-04-26
Aquaporin-4 (AQP4) water channels are normally concentrated at astrocyte end-feet ensheathing cerebral microvessels. Ear
Score: 0.705 · unknown disease · 2026-04-26
Pericyte loss in Alzheimer's disease leads to proteolytic shedding of PDGFRβ into circulation, providing a blood-accessi
Score: 0.690 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The pathogenesis of frontotemporal dementia with GRN mutations (FTD-GRN) involves
Score: 0.690 · neurodegeneration · 2026-04-25
Aβ initiates tau missorting, but persistent degeneration is then maintained by activated microglia through C1q/C3-CR3-me
Score: 0.685 · unknown disease · 2026-04-26
Plasma fibrinogen leaks across the compromised BBB and undergoes coagulation cascade activation and cross-linking by fac
Score: 0.670 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The molecular foundation of this hypothesis centers on the concept of trained imm